Amylyx Pharmaceuticals, Inc. (AMLX)
15.30
+0.13
(+0.86%)
USD |
NASDAQ |
Mar 02, 16:00
15.20
-0.10
(-0.65%)
Pre-Market: 08:44
Amylyx Pharmaceuticals Research and Development Expense (TTM) : 91.51M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Rapt Therapeutics, Inc. | 82.87M |
| Disc Medicine, Inc. | 170.36M |
| Cytokinetics, Inc. | 405.90M |
| Ionis Pharmaceuticals, Inc. | 914.12M |
| MediciNova, Inc. | 7.098M |